Method for treating cancer
US9925192B2 · kind B2 · utility
13Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2015 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Feb 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of cancer by administering a therapeutically effective amount of a cyclin-dependent kinase (CDK) inhibitor with a therapeutically effective amount of a B cell chronic lymphocytic leukemia/lymphoma 2 inhibitor (“B Cell CLL/Lymphoma 2”, or “BCL-2”). Administration of the CDK inhibitor and BCL-2 inhibitor can be simultaneous, successive or separate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.